Zimbabwe has turned down a significant American health deal worth 367 million US dollars (272 million pounds) over five years due to the United States' insistence on sensitive information.
This move came to light following a government memo from December was leaked, indicating that President Emmerson Mnangagwa felt the arrangement was "skewed".
A government representative later explained that the US was requesting health data for scientific study and commercial purposes while was unwilling to guarantee the resulting advantages from future medical innovations.
"We are forced to start the difficult and regrettable process of ending our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had furnished more than $1.9bn in health funding to Zimbabwe over the last two decades.
A doctors' association in Zimbabwe has urged more negotiations to reach a deal suitable to all parties so the country's critical HIV programme can proceed.
Wider Implications
Zimbabwe's decision comes after a similar case in neighbouring Kenya, where a high court suspended a similar health funding agreement following legal challenges were filed about the safety of Kenyans' health data.
Since resuming the presidency last year, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
USAID had managed assistance for the American government, but Trump claimed its expenditure was "inefficient" and his government was seeking government-to-government agreements to enhance transparency and accountability.
Based on statements, 16 nations in Africa have to date signed similar agreements, representing over $18.3bn in new funding.
Specifics of the Rejected Deal
This assistance for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation might have yielded immense advantages for Zimbabwean communities, particularly the 1.2 million currently on HIV treatment through US-supported initiatives," Tremont commented.
However, official spokesman Nick Mangwana argued the proposed deal was "asymmetrical".
"Our nation was requested to provide its biological resources and data over an extended period, without any equivalent promise of access to any medical innovations – like new medicines or tests – that might be developed from that shared data," his statement read.
"Effectively, our nation would provide the raw materials for scientific discovery with no assurance that the resulting innovations would be available to our population if a new pandemic arise."
National Interest and International Frameworks
Mangwana further noted that the American exit from the global health body and its push of bilateral health agreements were undermining systems previously set up via the international health agency.
Mangwana cited its Pandemic Benefit-Sharing system designed to manage future pandemics.
"This system is intended to guarantee that when a country contributes its data, the resulting advantages – including medicines and cures – are shared equitably, not commercialised solely by those with the capability to develop them."
These objections regarding the US deal "should not be misconstrued as opposition to America," he added.
"We are open to ongoing discussions with our US partners on how future collaboration could be designed in a way that respects the independence and dignity of both nations."
Health Experts Reaction
Medical experts expressed it acknowledged the official position, but urged that negotiations need to persist considering much of the country's HIV programmes were funded by external financing.
"If technical issues arise, including those involving information security or agreement terms, these can often be resolved via technical clarification and mutually agreed protections," it said.
This impasse highlights the complex tensions between receiving vital foreign assistance and safeguarding local interests in an ever more interconnected world.